Chaiken BH, Goldberg BI, Segal JP. Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis. N Engl J Med. 1950;242(23):897–8.

Article  CAS  PubMed  Google Scholar 

VanWyk JJ. Hoffmann CR Periarteritis nodosa: A case of fatal exfoliative dermatitis resulting from “dilantin sodium” sensitization. Arch Intern Med. 1948;81:605.

Article  CAS  Google Scholar 

Nagata T, Kawamura N, Motoyama T, et al. A case of hypersensitivity syndrome resembling Langerhans cell histiocytosis during phenobarbital prophylaxis for convulsion. Jpn J Clin Oncol. 1992;22(6):421–7.

CAS  PubMed  Google Scholar 

Bessmertny O, Pham T. Antiepileptic hypersensitivity syndrome: clinicians beware and be aware. Curr AllergyAsthma Rep. 2002;2:34–9.

Article  Google Scholar 

Handoko KB, van Puijenbroek EP, Bijl AH, Hermens WA, Zwart-van Rijkom JE, Hekster YA, Egberts TC. Influence of chemical structure on hypersensitivity reactions induced by antiepileptic drugs: the role of the aromatic ring. Drug Safety. 2008;31(8).

De Vriese AS, Philippe J, Van Renterghem DM, De Cuyper CA, Hindryckx PH, Matthys EG, Louagie A. Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature. Medicine. 1995;74(3):144–51.

Article  PubMed  Google Scholar 

Chadwick DW, Shaw MD, Foy P, Rawlins MD, Turnbull DM. Serum anticonvulsant concentrations and the risk of drug induced skin eruptions. J Neurol, Neurosurg Psychiatry. 1984;47(6):642–4.

Article  CAS  PubMed  Google Scholar 

Arif H, Buchsbaum R, Weintraub D, et al. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology. 2007;68(20):1701–9.

Article  CAS  PubMed  Google Scholar 

Blaszczyk B, Szpringer M, Czuczwar SJ, Lason W. Single centre 20 year survey of antiepileptic drug-induced hypersensitivity reactions. Pharmacol Rep. 2013;65(2):399–409.

Article  PubMed  Google Scholar 

Sullivan JR, Shear NH. Drug eruptions and other adverse drug effects in aged skin. Clin Geriatr Med. 2002;18(1):21–42.

Article  PubMed  Google Scholar 

Locharernkul C, Shotelersuk V, Hirankarn N. Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions. J Clin Neurosci. 2011;18(10):1289–94.

Article  CAS  PubMed  Google Scholar 

Guvenir H, Dibek Misirlioglu E, Civelek E, et al. The frequency and clinical features of hypersensitivity reactions to antiepileptic drugs in children: a prospective study. J Allergy Clin Immunol Pract. 2018;6(6):2043–50.

Article  PubMed  Google Scholar 

Beylot C. Pustuloses exanthematiques aigues generalisees. Ann Dermatol Venereol. 1980;107:37–48.

CAS  PubMed  Google Scholar 

Levy ZD, Slowey M, Schulder M. Acute generalized exanthematous pustulosis secondary to levetiracetam and valproic acid use. Am J Emerg Med. 2017;35(7):1036-e1.

Article  Google Scholar 

Kley C, Murer C, Maul JT, Meier B, Anzengruber F, Navarini AA. Rapid involution of pustules during topical steroid treatment of acute generalized exanthematous pustulosis. Case Rep Dermatol. 2017;9(1):135–9.

Article  PubMed  PubMed Central  Google Scholar 

Ingen-Housz-Oro S, Hotz C, Valeyrie-Allanore L, Sbidian E, Hemery F, Chosidow O, Wolkenstein P. Acute generalized exanthematous pustulosis: a retrospective audit of practice between 1994 and 2011 at a single centre. Br J Dermatol. 2015;172(5):1455–7.

Article  CAS  PubMed  Google Scholar 

Lee HY, Chou D, Pang SM, Thirumoorthy T. Acute generalized exanthematous pustulosis: analysis of cases managed in a tertiary hospital in Singapore. Int J Dermatol. 2010;49(5):507–12.

Article  PubMed  Google Scholar 

Choi MJ, Kim HS, Park HJ, Park CJ, Lee JD, Lee JY, Kim HO, Park YM. Clinicopathologic manifestations of 36 Korean patients with acute generalized exanthematous pustulosis: a case series and review of the literature. Ann Dermatol. 2010;22(2):163.

Article  PubMed  PubMed Central  Google Scholar 

Chang SL, Huang YH, Yang CH, Hu S, Hong HS. Clinical manifestations and characteristics of patients with acute generalized exanthematous pustulosis in Asia. Acta Derm-Venereol. 2008;88(4):363–5.

Article  PubMed  Google Scholar 

O’Brian M, Carr CL, Thomas C, Dominguez AR, Mauskar M. Clinical characteristics and management of acute generalized exanthematous pustulosis with haemodynamic instability. Skin Health Disease. 2021;1(4): e74.

Article  PubMed  PubMed Central  Google Scholar 

Yanes D, Nguyen E, Imadojemu S, Kroshinsky D. Cyclosporine for treatment of acute generalized exanthematous pustulosis: A retrospective analysis. J Am Acad Dermatol. 2020;83(1):263–5.

Article  CAS  PubMed  Google Scholar 

Meiss F, Helmbold P, Meykadeh N, Gaber G, Marsch W, Fischer M. Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-α antibody infliximab: report of three cases. J Eur Acad Dermatol Venereol. 2007;21(5):717–9.

Article  CAS  PubMed  Google Scholar 

Zhang L, Xu Q, Lin T, Ruan S, Lin M, Bao C, Zhang J, Liu T, Gong T, Ji C. Case report: successful treatment of acute generalized exanthematous pustulosis with secukinumab. Front Med. 2021;16(8): 758354.

Article  Google Scholar 

Creadore A, Desai S, Alloo A, et al. Clinical Characteristics, Disease Course, and Outcomes of Patients With Acute Generalized Exanthematous Pustulosis in the US. JAMA Dermatol. 2022;158(2):176–83. https://doi.org/10.1001/jamadermatol.2021.5390.

Article  PubMed  Google Scholar 

Sidoroff A, Dunant A, Viboud C, Halevy S, Bouwes Bavinck JN, Naldi L, Mockenhaupt M, Fagot J-P, Roujeau J-C. Risk factors for acute generalized exanthematous pustulosis (AGEP)—results of a multinational case–control study (EuroSCAR). Br J Dermatol. 2007;157(5):989–96. https://doi.org/10.1111/j.1365-2133.2007.08156.x.

Article  CAS  PubMed  Google Scholar 

Sultan SM, Daniels LM. Levetiracetam-Induced Acute Generalized Exanthematous Pustulosis. Pharmacotherapy: J Human Pharmacol Drug Therapy. 2011;31(4):440.

Article  Google Scholar 

Guevara-Gutierrez E, Uribe-Jimenez E, Diaz-Canchola M, Tlacuilo-Parra A. Acute generalized exanthematous pustulosis: report of 12 cases and literature review. Int J Dermatol. 2009;48(3):253–8.

Article  PubMed  Google Scholar 

Skalli S, Barret P, Villier C, Bussières JF. Carbamazepine-Induced Acute Generalized Exanthematous Pustulosis: A Case Report. J Pediatr Pharmacol Therap. 2011;16(1):61–5.

Google Scholar 

Cacoub P, Musette P, Descamps V, Meyer O, Speirs C, Finzi L, Roujeau JC. The DRESS syndrome: a literature review. Am J Med. 2011;124(7):588–97.

Article  CAS  PubMed  Google Scholar 

Descamps V, Saïd BB, Sassolas B, Truchetet F, Avenel-Audran M, Girardin P, Guinnepain MT, Mathelier-Fusade P, Assier H, Milpied B, Modiano P. Prise en charge du drug reaction with eosinophilia and systemic symptoms (DRESS). In Annales de Dermatologie et de Vénéréologie. 2010;137(11): 703-708. Elsevier Masson.

Cabañas R, Ramírez E, Sendagorta E, Alamar R, Barranco R, Blanca-López N, Doña I, Fernández J, Garcia-Nunez I, García-Samaniego J, Lopez-Rico R. Spanish guidelines for diagnosis, management, treatment, and prevention of DRESS syndrome. J Investig Allergol Clin Immunol. 2020;30(4):229–53.

Article  PubMed  Google Scholar 

Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M, Grange A, Amarger S, Girardin P, Guinnepain MT, Truchetet F. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol. 2013;168(3):555–62.

Article  CAS  PubMed  Google Scholar 

Redondo P, De Felipe I, De la Pena A, Aramendia JM, Vanaclocha V. Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine. Br J Dermatol. 1997;136(4):645–6.

Article  CAS  PubMed  Google Scholar 

Lee AY, Choi J, Chey WY. Patch testing with carbamazepine and its main metabolite carbamazepine epoxide in cutaneous adverse drug reactions to carbamazepine. Contact Dermatitis. 2003;48(3):137–9.

Article  CAS  PubMed  Google Scholar 

Barbaud RP, Trechot JP, Ehlinger N, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol. 1998;139(1):49–58.

Article  CAS